The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil

In Brazil, inclusion and exclusion of health technologies within the Unified Health System (SUS) is the responsibility of the National Committee for Health Technology Incorporation (CONITEC). A recent Cochrane systematic review demonstrated that intramuscular interferon beta 1a (IFN-β-1a-IM) was inf...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 2018-02, Vol.36 (2), p.161-173
Hauptverfasser:	Lemos, Livia Lovato Pires de, Guerra Júnior, Augusto Afonso, Santos, Marisa, Magliano, Carlos, Diniz, Isabela, Souza, Kathiaja, Pereira, Ramon Gonçalves, Alvares, Juliana, Godman, Brian, Bennie, Marion, Zimmermann, Ivan Ricardo, dos Santos, Vânia Crisitna Canuto, Pretramale, Clarice Alegre, Acurcio, Francisco de Assis
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Immunologic - therapeutic use Brazil Cancer therapies Care and treatment Cost analysis Diagnosis Drugs Failure Health Administration Health aspects Health Economics Health technology assessment Humans Injections, Intramuscular Interferon Interferon beta Interferon beta-1a - therapeutic use Internet Literature reviews Magnetic resonance imaging Medicin och hälsovetenskap Medicine Medicine & Public Health Multiple sclerosis Multiple Sclerosis, Relapsing-Remitting - drug therapy National Health Programs NMR Nuclear magnetic resonance Patients Pharmacoeconomics and Health Outcomes Practice Guidelines as Topic Public Health Quality of Life Research Review Review Article Studies Systematic review Technology Treatment Failure Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!